|
MechanismPPP1R8 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Ernest Pharmaceuticals, Lcc
0 Patents (Medical) associated with Ernest Pharmaceuticals, Lcc
100 Deals associated with Ernest Pharmaceuticals, Lcc
100 Translational Medicine associated with Ernest Pharmaceuticals, Lcc